Have any idea what it costs to create, test, then get a new drug into the market? The producer of any new drug needs to have a certain period of time with a monopoly on the new drug just to recuperate the development costs of the said new drug.
Source is Wiki..................................Developing a new prescription medicine that gains marketing approval is estimated to cost drugmakers $2.6 billion according to a recent study by Tufts Center for the Study of Drug Development and published in the Journal of Health Economics.
Is the system that makes it so expensive to get life-saving medication to patients something we should preserve and try to accommodate with our policies, or overthrow and replace with something that works better?
You realize you are making the tacit argument that an unregulated market does not work for pharmaceuticals: competition is harmful to patients because it drives prices "too low", and that market participants are too stupid to understand that size matters.Healthcare is different, though. You have a captive audience, or at least, you have consumers who must have medication to live. For example, I have to take my blood pressure medicine. The next thing you might consider is that there is competition which should drive down prices. But that isn't really what is at the heart of capitalism. What is at the heart is winning and monopolies and market barriers and price fixing and patenting and IP in order to block competition because that guarantees profit. Only through regulation is that nature of capitalism somewhat mitigated, and I say somewhat, because regulation thus far hasn't stopped market barriers. Much of Big Pharma, too, hasn't produced new drugs recently and so they acquire smaller companies which is another way of crushing competition. Maybe take a look at this guy:
https://en.wikipedia.org/wiki/Martin_Shkreli
Competition does drive down drug prices--just look at the price of common generics. In fact, the price is driven too low in many cases (there isn't enough profit for the drug companies to care about ensuring supply, thus production glitches translate to patients not being able to get the medicine they need.)
The abuses we keep hearing about are uncommon drugs where there was so little profit that only one company was making them.
Also, the pattern we see these days with buying up smaller companies rather than researching is not a means of crushing competition. Rather, this is taking advantage of the stupidity of many investors. A company is formed to try to take a drug from a prospect to something on the market. These small companies exist only for this purpose, they do not have the ability to actually be viable in the marketplace. If the drug fails they're wiped out (all investors getting basically zero), if the drug succeeds they're bought out by one of the big players that can actually produce it, the investors get a big payoff. It's like playing the lottery, the big payoffs aren't enough to compensate for the flops but if investors will keep buying the big guys have no reason not to continue this model.
Pharmaceuticals are a natural monopoly?You realize you are making the tacit argument that an unregulated market does not work for pharmaceuticals: competition is harmful to patients because it drives prices "too low", and that market participants are too stupid to understand that size matters.
This is true. For any product where the end user doesn't have the ability to not obtain the item in question, but where the market incapable of supporting a number of competing suppliers, the only sensible way to provide that product is through government. Natural monopoly plus 'free' markets equal shortages - either because to little is made, or because the people who need it cannot afford it, or most often, both.
Squire Patton BoggsJoseph Crowley (born March 16, 1962) is an American politician and lobbyist who served as U.S. Representative from New York's 14th congressional district from 1999 to 2019. In 2018 he was defeated by Democratic primary challenger Alexandria Ocasio-Cortez in what was viewed as one of the largest upsets of the midterm elections.[1]
During his tenure, Crowley served as Chair of the House Democratic Caucus from 2017 to 2019, as well as the local chairman of the Queens County Democratic Party from 2006 to 2019. He previously served in the New York State Assembly from 1987 to 1998.[2][3] After leaving Congress, he joined the Washington, D.C., lobbying and law firm Squire Patton Boggs.[4]
From September 2011, The King who hates Queens - JuniperCivic.comSquire Patton Boggs is currently the third-largest lobbying firm in the U.S. after Akin Gump Strauss Hauer & Feld and Brownstein Hyatt Farber Schreck.[8] The lobbying arm, long managed by Thomas Hale Boggs Jr., is managed by former United States Senators John Breaux and Trent Lott.[9]
From April 11 of last year, Joseph Crowley, 56 Years Young and Ready to Succeed the Old GuardJoe Crowley hates Queens. The Congressman, whose gerrymandered district includes parts of the Bronx and Queens has such distain for his home borough that despite wearing the hat of chairman of the Queens Democratic Party he has abandoned us for greener pastures, namely the affluent Washington suburb of Arlington, Va.
According to the New York Post, in 2004 Crowley bought the Virginia house, registered his car and enrolled his three children in the community's nationally renowned public schools ‒ foregoing New York City's educational system. Up until the July 8, 2011 article exposing this, Crowley claimed to live in his mother's house in Woodside even though neighbors never saw him.
The rest of the article discussed this Democratic Party apparatchik's likely career future.Current leadership at least two decades older than New York Democrat
When the inevitable generational change starts in the top ranks of the House Democrats, Joseph Crowley is planning to be first in line.
Pharmaceuticals are a natural monopoly?You realize you are making the tacit argument that an unregulated market does not work for pharmaceuticals: competition is harmful to patients because it drives prices "too low", and that market participants are too stupid to understand that size matters.
This is true. For any product where the end user doesn't have the ability to not obtain the item in question, but where the market incapable of supporting a number of competing suppliers, the only sensible way to provide that product is through government. Natural monopoly plus 'free' markets equal shortages - either because to little is made, or because the people who need it cannot afford it, or most often, both.
https://en.wikipedia.org/wiki/Natural_monopoly
That doesn't make a lot of sense. If the disease is that rare and the patients' ability to pay is that low, how was it profitable for a supposed natural monopolist to develop the drug in the first place? "Natural monopolies arise where the largest supplier in an industry, often the first supplier in a market, has an overwhelming cost advantage over other actual or potential competitors". Well, what is that advantage? How can low aggregate demand give the first supplier an overwhelming cost advantage? Manufacturing costs are typically a negligible fraction of monopoly drug prices.
Some are, yes. Where aggregate demand is sufficiently low, the market cannot support more than one manufacturer. And some diseases are quite rare.
That doesn't make a lot of sense. If the disease is that rare and the patients' ability to pay is that low, how was it profitable for a supposed natural monopolist to develop the drug in the first place? "Natural monopolies arise where the largest supplier in an industry, often the first supplier in a market, has an overwhelming cost advantage over other actual or potential competitors". Well, what is that advantage? How can low aggregate demand give the first supplier an overwhelming cost advantage? Manufacturing costs are typically a negligible fraction of monopoly drug prices.
Some are, yes. Where aggregate demand is sufficiently low, the market cannot support more than one manufacturer. And some diseases are quite rare.
Like Don said, maybe take a look at this guy:
https://en.wikipedia.org/wiki/Martin_Shkreli. He became the most hated man in America when he used his monopoly power to jack a drug price from $13 to $750. According to https://en.wikipedia.org/wiki/Pyrimethamine, "In 2016, a group of high school students from Sydney Grammar supported by Matthew H. Todd from the University of Sydney prepared pyrimethamine as an illustration that the synthesis is comparatively easy and the price-hike unjustifiable. His team produced 3.7 g for US$20, which would have been worth between US$35,000 and US$110,000 in the United States at the time." That works out to no more than 40 cents a pill. There are a number of actual pharma companies competing to provide it at lower prices than that. Just not in the U.S. Shkreli was gaming the regulatory system, not the market.
You may of course be right that there are some drugs out there just hard enough to make, and needed by just the right number of people, that the market would support one company but not two. But the conditions would have to be just right, which means they're probably so atypical that you can't actually name such a drug. Drugs are generally too easy to make and other natural barriers to entry are just too low to constitute a serious obstacle.
I have a feeling she could beat Angelo with half her brain neurons tied behind her back.
Oh god oh fuck don't stopEvery Democrat front runner for president quickly endorsed the GND, evidently before reading further details of the plan in a now deleted post at AOC's website. These plans included decommissioning all US nuclear plants, adding high-speed rail lines at a scale where air travel stops becoming necessary, replacing every combustion engine vehicle and, of course, the nationwide destruction or retrofitting of more than 120 million buildings.
Oh god oh fuck don't stopEvery Democrat front runner for president quickly endorsed the GND, evidently before reading further details of the plan in a now deleted post at AOC's website. These plans included decommissioning all US nuclear plants, adding high-speed rail lines at a scale where air travel stops becoming necessary, replacing every combustion engine vehicle and, of course, the nationwide destruction or retrofitting of more than 120 million buildings.
Alexandria Ocasio-Cortez impersonator cracks up the internetA conservative group with the single aim of unseating Rep. Alexandria Ocasio-Cortez spent $32,000 on Monday to convince New York City voters that she doesn’t represent their interests.
The Stop AOC PAC, started in March by Virginia lawyer Dan Backer, plans to file its expenditure report Wednesday.
Can't they do any better?An 8-year-old’s impersonation of Rep. Alexandria Ocasio-Cortez is taking social media by storm.
“Like, I want to talk about, like, climate change. Because, like, there’s no doubt cow farts are making the climate change,” Ava Martinez says in a video posted to Twitter this week.
“Like, in July, the climate was 96 degrees and in February the climate was 36 degrees. OMG, like that’s a huge change in the climate in only” — she pauses to count her fingers — “four months!”
“At this rate, the world is going to end in exactly 12 years,” adds Ava, who sports red lipstick and AOC-style glasses.
Alexandria Ocasio-Cortez plans to visit Kentucky even after a Republican politician changed his mind about his inviting her to do so.New York Rep. Alexandria Ocasio-Cortez admitted she was not “rational” for challenging powerful incumbent Joe Crowley, according to a trailer released Monday for a Netflix documentary about her win.
“If I was a rational person I would have dropped out of this race a long time ago,” the then-candidate says in the clip. “He’s gonna tell me I’m small. That I’m young. That I’m inexperienced.”